About the Conference

会议简介

The Annual Conference is the association’s largest gathering of the year. It runs a full day and draws people from every stage of drug development, including discovery scientists, clinicians, regulatory and CMC specialists, founders and investors.

年会是协会一年中规模最大的活动，全天举行，参加者来自新药研发的各个环节，包括从事早期发现的科学家、临床专家、法规与 CMC 专业人员，以及创业者与投资人。

This year’s theme is Converging Innovations: AI, Next-Generation Biomedical Science, and Global Drug Development. Ten sessions run through the day, covering artificial intelligence and real world evidence, oncology, neuroscience, cardiovascular and metabolic disease, new approach methodologies and organoids, statistics and regulatory strategy, CMC, business development, and career development. The flyer lists them in full.

本届年会的主题为“创新汇聚：人工智能、新一代生物医学科学与全球药物研发”。全天共设十个专题环节，内容涵盖人工智能与真实世界证据、肿瘤、神经科学、心血管与代谢疾病、新方法学与类器官、统计与法规、CMC、商务拓展以及职业发展。完整安排详见宣传页。

We expect more than 300 people to attend, including over 150 executives from more than 75 companies, together with 17 sponsoring organizations. For many of our members this is the one day in the year when they can meet counterparts from other companies, catch up on the science, and find partners for their own work.

我们预计将有 300 余人出席，其中包括来自 75 家以上企业的 150 余位高管，以及 17 家赞助机构。对许多会员而言，这是一年中难得的机会，可以结识其他公司的同行、了解科学的最新进展，并为自己的工作寻找合作伙伴。

Registration is open. Seats are limited, so please register early.

报名现已开放。名额有限，敬请及早报名。